The full-scale manufacturing of nuclear medicines can now begin at Lucas Heights, following licence approval on June 13.
Part of Australia’s Nuclear Science and Technology Organisation (ANSTO), the ANSTO
Read More
Telix Pharmaceuticals offers prostate cancer imaging solution to US
Telix Pharmaceuticals has submitted a Drug Master File (DMF) to the US Food and Drug Administration for a sterile kit used in the detection of prostate cancer.
The 68Ga-PSMA-11 (PSMA Kit) is as a promising
Read More
Read More
VIC manufacturer targeting Japanese cancer treatment
Melbourne medical manufacturer Telix Pharmaceuticals has partnered with a major Japanese engineering company to market its TLX-250 imaging program for cancer patients.
JFE Engineering is an expert of cyclotron
Read More
Read More
Young workers face increased cancer risk at work
Exposure to the sun, diesel fumes and tobacco smoke at work has increased the likelihood of almost half of the Western Australian workforce to be diagnosed with cancer, a study has found.
Read More
Read More